New osteoarthritis treatments could boost quality of life

Successful development of a number of new osteoarthritis treatments could considerably boost the quality of life of people suffering from the condition, it has been claimed.

According to a new article published in the F1000 Medicine Reports, treatments such as autologous chondrocyte implantation and matrix-assisted autologous chondrocyte implantation could also reduce the amount of strain put on national health services as the Western world's population ages.

The article, which was compiled by Yves Henrotin and Jean-Emile Dubuc, said: "The huge financial burden emphasises the acute need for new and more effective treatments for cartilage defects, especially since there are few disease-modifying drugs or treatments for osteoarthritis."

Henrotin and Dubuc claimed that both aforementioned procedures had shown positive results but neither were ready for the wholesale treatment of cartilage defects in osteoarthritis sufferers.

"Further research is needed to simplify the implantation procedure and to improve the success level," they concluded.

A recent study in Arthritis Care & Research showed that self-management of osteoarthritis of the knee could dramatically improve people's pain scores.

<< Back

News provided by Adfero in collaboration with Biomet. Please note that all copy is (c) Adfero Ltd and does not reflect the views or opinions of Biomet unless explicitly stated.